Subacute Cutaneous Lupus — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Subacute cutaneous lupus erythematosus
Subacute cutaneous lupus erythematosus (SCLE) presents with photosensitive annular/polycyclic or papulosquamous lesions, typically on the upper trunk, shoulders, and arms. Unlike DLE, SCLE does NOT cause scarring (it heals without atrophy). Anti-Ro/SSA antibodies are positive in approximately 70-80% of SCLE patients. SCLE can be idiopathic or drug-induced (PPIs, Terbinafine, thiazides, TNF-alpha inhibitors). About 50% of SCLE patients meet criteria for SLE but tend to have milder systemic disease. Treatment includes sun protection, topical corticosteroids, and Hydroxychloroquine.
Reference: BAD 2016 Cutaneous Lupus Guidelines